| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. | Director | Common Stock | 9.5K | $94.9K | $9.99 | Sep 11, 2025 | Direct |
| Rapport Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 10.9K | Jun 17, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | Sep 11, 2025 | 1 | $79.1K | 4 | Sep 11, 2025 | Director |
| RAPP | Rapport Therapeutics, Inc. | Jun 17, 2025 | 1 | $0 | 4 | Jun 18, 2025 | Director |
| RAPP | Rapport Therapeutics, Inc. | Mar 12, 2025 | 1 | $61.2K | 4 | Mar 13, 2025 | Director |
| RAPP | Rapport Therapeutics, Inc. | Nov 7, 2024 | 1 | $0 | 4 | Nov 7, 2024 | Director |
| RAPP | Rapport Therapeutics, Inc. | Nov 7, 2024 | 0 | $0 | 3 | Nov 7, 2024 | Director |